Programme SOM0044 for Parkinson’s Disease
SOM0044 is a small molecule for the treatment of Parkinson’s disease.
Suven fails to meet target in trial of Alzheimer’s drug masupirdine
Suven fails to meet target in Phase II trial of Alzheimer’s drug masupirdine. Credit: Gordon Johnson from Pixabay.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
Close
-
CSM, a Clinigen company
CSM, a Clinigen company, focuses on clinical trial supplies and...
About
CSM, a Clinigen company, focuses on clinical trial supplies and biological sample management services.
FollowMake an Enquiry
-
SWIL Systems
ZUMEDU, created by SWIL Systems, provides cloud-based, end-to-end encrypted video...
About
ZUMEDU, created by SWIL Systems, provides cloud-based, end-to-end encrypted video conference solutions for clinical researchers, including contract research organisations (CROs), sponsors and institutions.
FollowMake an Enquiry
-
SOM Biotech
SOM Biotech is an Artificial Intelligence AI drug discovery and...
About
SOM Biotech is an Artificial Intelligence AI drug discovery and development company focused on the development of therapies for orphan indications through the proprietary AI-based drug discovery technology.
FollowMake an Enquiry